NCT06499649View on ClinicalTrials.gov

Assessment of the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Therapy for the Eradication of Helicobacter Pylori Infection.

NACompletedINTERVENTIONAL

Enrollment

270

Participants

Timeline

Start Date

July 3, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

May 5, 2025

Conditions

Helicobacter Pylori Infection

Interventions

DIETARY_SUPPLEMENT

IBSA Probiotics

Dietary supplement base on probiotic strains.

DIETARY_SUPPLEMENT

Placebo

The placebo does not contain functional components, and the appearance is indistinguishable from the comparison product.

Trial Locations (1)

40138

Policlinico S. Orsola - Malpighi - Università di Bologna, Bologna

All Listed Sponsors

lead

IBSA Farmaceutici Italia Srl

INDUSTRY

NCT06499649 - Assessment of the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Therapy for the Eradication of Helicobacter Pylori Infection. | Biotech Hunter | Biotech Hunter